Download English - Micromedex

GLOBAL
EDITION
Latin American
Edition | June 2016
Micromedex
®
INSIGHTS
Trusted Answers for Clinical Decision Support
INSIDE:
Pharmacovigilance: Building a Better Health System
Puerto Rico’s Hospital Auxilio Mutuo speaks to Truven Health
about the importance of patient engagement
ALSO:
Test your clinical
knowledge with
the Micromedex
Quiz!
Local events
not to miss
Tips and tricks
for Micromedex
users
Local news
and updates
Note From the Editors
Truven Health Analytics,™ an IBM® Company, is delighted to bring you the first issue of the Latin American
version of the Micromedex® Insights Newsletter, in which we share innovations from the healthcare sector,
news, significant regional issues, and the activities in which Micromedex® Solutions provides clinical knowledge.
Micromedex Solutions is an expert system that provides smart information to support clinical decisionmaking. It offers access to evidence-based information collected through a meticulous, certified editorial
process that is consistent throughout all areas of the hospital in order to improve the quality of patient safety
and healthcare. Present in more than 90 countries and with 40 years of experience, Micromedex Solutions
has become the gold standard for the provision of relevant clinical information in the healthcare industry.
At the beginning of the year Truven Health Analytics was acquired by IBM® Watson Health, making it a
world leader in the healthcare industry.
We hope you enjoy this first edition. If you would like to contribute with information on related issues at a
regional level, please write to us at [email protected].
Sincerely,
The Editors
What’s New
Industry news
Drug Used to Treat Cancer Gets ANVISA Approval for Leukemia
Read more at portal.anvisa.gov.br
Environmental Contingencies in the Metropolitan Area of the Valley of Mexico
Read more at cofepris.gob.mx
National Supplementary Health Agency Published List of Hospitals That Achieved Quality Standards
in Brazil
Read more at ans.gov.br
Flu Season Started Earlier in Brazil: Cases of H1N1 are Increasing
Read more at g1.globo.com
ANVISA Approves Importation of THC-Drugs for Treatment of Seizures, Parkinson, Chronic Pain
Read more at portal.anvisa.gov.br
Truven Health Analytics News
Have You Downloaded Your Micromedex Mobile Apps Yet?
If your institution has a subscription to Micromedex Solutions
online, why not download your free mobile apps today?
For instructions, visit truvenhealth.com/mobile/global.
Instructions are available in Spanish and Portuguese
for both Apple® and Android® devices.
If your institution does not yet subscribe to
Micromedex Solutions online, contact us at
[email protected].
New Spanish Language Website Now Live
DotLib, authorized distributor of Truven Health Analytics,
has launched a new Spanish-language website.
Visit micromedexlatam.com for more details
about Micromedex Solutions and how to get in
touch with your local representative.
3
Thought Leadership
Pharmacovigilance:
Building a Safer Health System
In Latin America, the creation of administratively independent regulatory
agencies began in the 1990s, consolidating the functions for the
registration, control, and monitoring of medicines, medical devices,
and other high-risk products.
Regular pharmacovigilance activities soon appeared
regional cooperation and opportunities for technical
across Latin America. These programs set up risk
cooperation, exchanging information on advances
management systems and guidelines for best practices.
in plans for cooperation between the organization
The reporting of the adverse effects of medicines to
and healthcare regulatory systems for medicines and
Ministries of Health drives the systematic monitoring
healthcare technology.
of drug-related problems (DRP) and actions aimed
at optimizing use and prevention to be incorporated
Latin-American regulatory agencies work together with
into health plans. This system of vigilance centers on
related international bodies for the common goal of
ensuring patient safety and quality healthcare.
protecting public health.
The first Meeting of Latin American and Caribbean
regulatory agencies was held in February 2006 in
Oaxaca City, Mexico, which brought to light the need
to establish regional priorities. Since then, regulatory
agencies in the region have met periodically to engender
4
The Beginning of Pharmacovigilance
Pharmacovigilance began in 1968 with the World
This means that support systems are needed that aim to
Health Organization (WHO)’s International
reduce the ambiguity of data in order to avoid erroneous
Pharmaceutical Vigilance program, created in response
conclusions. This is done through analysis of causality,
to the thalidomide crisis of 1961, in which the use of
where, using individual reports with clinical data,
thalidomide during pregnancy led to a high number of
algorithms or scales are used to find out about
cases of teratogenicity.
information arriving in the system and the quality
of this information, in terms of its consistency,
To ensure the safe and effective use of medicines
relevance, and adequacy.
through benefit-risk analysis, it is essential to use
mechanisms for assessing and monitoring adverse
An effective support system consists of obtaining
reactions, defined by the WHO as a “response to
information about medicines from secure and reliable
a drug which is noxious and unintended, that may
sources that are fully referenced and continually
present during treatment with a pharmaceutical
updated.
product, and which occurs at doses normally used
in humans for the prophylaxis, diagnosis, or therapy
of disease, or for the modifications of physiological
function.” This requires well-structured and organized
pharmacovigilance systems.
An effective support system consists of obtaining
information about medicines from secure and
reliable sources that are fully referenced and
continually updated.
5
Customer Focus
One Hospital’s Steps Toward
Improved Patient Education
Hospital Auxilio Mutuo in San Juan is the largest hospital in Puerto Rico and the Caribbean, with 130 years of
service under its belt. The hospital is committed to providing high-quality care with a dedicated group of more
than 600 doctors and over 2,000 employees to the 24,000-plus patients admitted annually.
Javier Havia Colon, Systems Analyst at the hospital, spoke to Truven Health about the importance of patient
engagement, and how providing the right information in the right format at the right time can facilitate patient
adherence, ultimately leading to better care outcomes.
Can you describe your organization and its functions?
What do you like about Micromedex?
Hospital Auxilio Mutuo; patient healthcare services.
Being able to quickly update information within the
Micromedex or PDR application.
How often do you face major responsibilities, concerns,
and challenges?
What have you been able to achieve through use of
Every day.
Micromedex?
We’re able to provide patients with information on
What were your main reasons for choosing Truven
their medicines in a clear and precise manner when they
Health as a partner?
are discharged.
For the Micromedex solution, also known as PDR, which
is related to medicines.
Would you recommend Micromedex and, if so, why?
Yes, because of its outstanding service and fast solutions
What were your main objectives when you decided to
for patient healthcare.
partner with Truven Health?
To use this product to give patients better advice on use
of medicines they are prescribed.
Healthcare professionals at Hospital Auxilio Mutuo have trusted Micromedex Solutions for almost a decade to
provide evidence-based clinical decision support for medication and toxicology management, as well as disease
and condition management.
Now, with the addition of evidence-based patient education integrated into the hospital information system,
clinicians at the hospital have immediate access to the patient-specific information they need directly in the
workflow — so they never have to interrupt what they’re doing to create, find, and share the information needed.
Hospital Profile:
Hospital Auxilio Mutuo
600+ doctors
2,000+ employees
24,000+ patients
admitted annually
6
Clinical Content Updates
Essential Zika Virus Resources Available in Micromedex
In response to the recent spread of the Zika virus, evidence-based resources continue to be updated in
Micromedex. New information concerning the reproductive risks of the Zika virus has recently been added,
and Medical Management information supports clinicians from a toxicology management perspective.
Micromedex Patient Education featuring CareNotes® provides easy-to-understand patient engagement and
education materials, in English and Spanish, for ambulatory care, discharge care, after care, and general information.
Disease and condition management information supports patient care decisions with:
§§ Background information including epidemiology, etiology, and pathophysiology
§§ Diagnostic testing and procedures
§§ Diagnosis and differential diagnosis
§§ Clinical evaluation and reassessment
§§ Treatment and prognosis
To view the full list of clinical content updates, visit micromedex.com/clinicalupdates/April2016.
The Best Care Calls for the Best Clinical Evidence
Trusted evidence built upon unparalleled editorial review methodologies for confident clinical decisions.
What is the Micromedex Solutions Editorial Process?
Micromedex Knowledge-Development Process
Patient safety is a priority, and healthcare professionals
need trusted evidence to support critical decisions with
confidence.
The Truven Health Analytics Micromedex Solutions
Surveillance
Evaluation
Ongoing surveillance of the
world’s biomedical literature
and regulatory actions.
Identification of the highestquality literature from a
variety of sources, and
determination of clinical
significance.
proven editorial processes and rigorous training of
in-house editorial staff are unparalleled in the industry.
Because Truven Health clinicians complete extensive
Content Creation
evaluation and synthesis of the literature and assess
information across multiple content areas, Micromedex
customers can be confident that the clinical content
contains the most accurate, relevant, and consistent
Objectively validated by
academics and professionals.
Our specialists work across
drug, disease, toxicology,
and patient education
for consistency across all
content sets.
Final Review and Publish
Internal and External
Review
Fortified Evidence
information available.
The trusted and proven procedures used to create
the Micromedex clinical content include a multi-step
editorial process and documented policies, as well as
ongoing surveillance and critical evaluation of primary
literature. The in-house team of more than 90 clinically-
Content reviewed for clinical
accuracy and relevance.
Additional review by editorial
board members for critical
content areas.
trained editorial staff identify the highest quality
literature from a variety of sources, and determine
clinical significance to support healthcare professionals
in clinical decisions on patient care.
7
Quiz
Test Your Clinical Knowledge!
We invite you to take part in this issue’s quiz. If you have access to Micromedex Solutions, use it as a reference for
finding the answers to the quiz. Then check your answers at micromedex.com/June2016Quiz. If you don’t have
access to Micromedex, contact your local representative to find out how you can take a look. Contact details are on
the back of this issue.
1. F
or the new ANVISA-approved indication
4. When started on dasatinib, women must be
Philadelphia chromosone positive chronic
reminded about which of the following?
myelogenous leukemia, chronic phase, newly
a. Avoid pregnancy during treatment and use birth
diagnosed, what is the recommended dose for
SPRYCEL® (dasatinib)?
a. 20 mg
b. 50 mg
c. 100 mg
d. 120 mg
e. 140 mg
2. What is the Micromedex Strength of Evidence
recommendation for using dasatinib for this newly
ANVISA-approved indication?
a. Class I — Recommended
b. Class IIa — Recommended, In Most Cases
c. Class IIb — Recommended, In Some Cases
d. Class III — Not Recommended
e. Class Indeterminate — Evidence Inconclusive
3. The concomitant use of dasatinib and fluconazole...
a. Has excellent documentation
b. Is considered major in severity
c. May result in increased dasatinib plasma
concentrations
d. A and C above are correct
e. May result in decreased dasatinib plasma
concentrations
control for two weeks after treatment
b. Postpone pregnancy during and for up to 30 days
after discontinuing treatment
c. Risk to fetal development has been confirmed,
and should be avoided at all cost
d. Usually, once a patient is started on dasatinib, the
chances of pregnancy are limited
e. Whilst fetal risk cannot be ruled out, pregnancy is
generally safe
5. It is recommended that for all patients on dasatinib,
a Complete Blood Count (CBC) be drawn...
a. Every week for the duration of the therapy
b. Every other week for the first three months and
then monthly for the duration of the therapy
c. Once a month for the first six months and then
once every three months
d. Weekly for the first two weeks of therapy and
then monthly thereafter
e. Monthly for the first three months and then every
six weeks for the next six months
Check your answers at micromedex.com/June2016Quiz.
The first five respondents to submit correct answers
online will be mentioned in the next edition of the
newsletter!
8
Product Updates
The Latest Product Updates From
Micromedex Solutions
Local Brazilian Drugs to Be Included in EMR/Pharmacy
System Support
SabiaMed to Deliver Micromedex Evidence-Based
Clinical Decision Support and Patient Education
Later this year, Truven Health will be introducing local
SabiaMed, provider of Hospital Information Systems,
Brazilian drugs into its automated Medication Advisory
has entered into an alliance with Truven Health to resell
Screening (MAS) module within Electronic Medical
integrated Micromedex Solutions patient education
Record (EMR)/Pharmacy System Support. This will
and clinical decision support content and resources
enable clinicians to use an automated solution to
to its ClinNext EHR customers. Truven Health has
screen a patient’s medications for potentially harmful
announced a multi-year agreement with SabiaMed to
drug interactions directly within the clinical workflow.
resell medication, disease, laboratory and other clinical
Inclusion of Brazilian brand and generic drug interactions
decision support to its Latin American customers.
will improve patient safety, enhance patient care
SabiaMed also will resell Micromedex CareNotes patient
outcomes, and help to reduce the cost associated with
and consumer education.
adverse drug events.
MV Integrates Micromedex Solutions into SOUL MV®
Good News for Micromedex Customers Also Using BMJ
Best Practice
In February this year, MV announced a partnership
BMJ Best Practice users now have the option to
to integrate Micromedex into its Electronic Health
seamlessly access Micromedex Solutions evidence-
Record (EHR) solution, SOUL MV. The integration
based drug content at the point of care. Micromedex
allows clinicians to access the world’s leading
drug monographs integrated into BMJ Best Practice can
source of evidence-based medication and condition
provide clinicians with resources to help better inform
management information, as well as patient education
prescribing, medication management strategies, and
in 15 languages, including Brazilian Portuguese and
treatment decisions. This new feature combines content
Spanish. This means faster access to the information
from two of the most trusted evidence-based resources,
needed when confirming diagnosis and treatment,
providing our users with a unified view and single access
including efficiency in assessing drug interactions, all
to support clinical decision-making at the point of care
while supporting better patient education to increase
for better patient outcomes. To learn more, view the
adherence and engage patients. Read the full press
information sheet at micromedex.com/bmj.
release at micromedex.com/mv.
Philips Tasy Users Benefit From Micromedex Drug
Interactions Evidence
Interactions between medications and food or lab tests
can be harmful to patients that require therapy with the
use of several different medications at the same time,
greatly increasing the risk of complications and adverse
events. With the integration of Micromedex in the Tasy
System, healthcare professionals can access clinical
information during treatment evaluation, providing
clinically relevant and consistent evidence directly within
their workflow, facilitating faster decision-making and
assessment of possible risks to the patient. Read the full
press release at micromedex.com/philips.
9
Tips & Tricks
Enhanced Drug Class Workflow
In addition to the Drug Classes link in the Resources section on the homepage, a drug class workflow is now
offered in Micromedex Clinical Knowledge, with the ability to browse drug classes from the drug dashboard after
searching for a drug.
If for example, during a drug shortage of methimazole, a substitute is required for the treatment of hyperthyroidism,
Micromedex users can search for the drug on the homepage, and the drug classes of methimazole can be viewed
from the drug dashboard. Select Antithyroid Agent from the drug classes, and an alphabetical list of drugs in that
class will be displayed, with the option to jump straight to another letter in the alphabet for efficiency if the list is
long. Select a drug to view further detail to support treatment decisions.
Alternatively, select the Drug Classes link on the Resources section of the homepage. This will display an alphabetical
list of drug classes, and users can select Antithyroid Agent to view the drugs in that class.
10
Events
Event Feature
The International Congress of the O.F.I.L. and the National Congress for
the Rational Use of Medicines
Puerto Vallarta, Mexico | 3-5 March, 2016
On March 3, 4, and 5 of this year, the 17th International
numerous benefits of trusted clinical decision support
Congress of the Organización de Farmacéuticos
for healthcare professionals, highlighting the critical
Iberolatinoamericanos (OFIL) and the 5th National
importance of being able to draw on current information
Congress for the Rational Use of Medicines were held to
on medicines, diseases, patient education, and
provide updates on advances made across the pharmacy
toxicology.
profession in Latin America and the Iberian Peninsula.
20 countries were represented by 350 participants from
Micromedex Solutions adapts to the needs related
North America, Latin America, and Europe.
to patient safety objectives and helps optimize the
professional development of pharmacists, physicians,
Conference participants attended workshops, keynote
and nurses, updating them on scientific and
speeches, roundtables, and an exhibition of research
technological developments, so that they can always
posters, all related to the safe and rational use of
stay at the leading edge of the international sector.
medicines, from a multidisciplinary perspective.
Linked to the support of continual improvement
If you plan on attending any of the events below and
of pharmacy services, Micromedex Solutions took
would like to meet the Micromedex team, please get in
part as an exhibitor, providing information on the
contact to let us know.
Tradeshows and Events Not to Miss:
Congreso de Bibliotecas
Universitarias y
Especializadas
Santiago, Chile
1-2 June 2016
Congreso Nacional de
Farmacia Hospitalaria
(ACQFH)
Bogotá, Colombia
25 August 2016
XIV International and
X Mexican Congress of
Toxicology (RITSQ)
Mérida, Mexico
2-6 October 2016
III Congreso Internacional
De Especiales Pediátricas
Y Taller De Nutrición
Pediátrica
Quito, Ecuador
1-4 June 2016
Annual Convention of
the Asociación de Salud
Primaria de Puerto Rico
Rio Grande, Puerto Rico
September 2016
HIMSS Latin America
Conference
São Paulo, Brazil
4-6 October 2016
Convención Annual del
Colegio de Administradores
de Salud de PR (CASS) Fajardo, Puerto Rico
22-26 June 2016
State HIT Summit Puerto Rico
July 2016
Puerto Rico Hospitals
Community Educational
Conference: Quality
Improvement in Puerto Rico:
Requirements, Measures,
and Expectations
San Juan, Puerto Rico
1 September 2016
X Congreso Nacional de
Farmacovigilancia (AMFV)
Mérida, Mexico
12-14 October 2016
Philips Connect Day
São Paulo, Brazil
18-19 October 2016
Puerto Rico Medical
Directors Academy
Dorado, Puerto Rico
21-23 October 2016
Convención de la
Asociación de Hospitales de
Puerto Rico (AHPR)
San Juan, Puerto Rico
October 2016
11
Want more content like this?
Subscribe to receive the next issue!
Visit micromedex.com/latam/subscribe
Interested in Micromedex?
Contact your regional representative for more information.
Contact Info
Latin America Regional Director, Truven Health Analytics:
Jorge Manosalva
[email protected]
+1 303 807 1779
Argentina, Chile, Colombia, Peru,
Ecuador:
Uruguay, & Venezuela:
Dot.Lib, approved distributor
Dot.Lib, approved distributor
[email protected]
[email protected]
+593 9 9481 1382
+57 3108128804
Mexico:
Brazil:
Dot.Lib, approved distributor
Dot.Lib, approved distributor
[email protected]
[email protected]
[email protected]
+55 11 98558 8025
+52 1 55 2190 8657
Caribbean & Central America:
Rubali Professionals Inc., approved distributor
[email protected]
+1 787 791 3909
Truven Health Analytics, an IBM Company
Truven Health Analytics, an IBM® Company, delivers the answers that clients need to improve healthcare quality and access while reducing costs. We provide marketleading performance improvement solutions built on data integrity, advanced analytics, and domain expertise. For more than 40 years, our insights and solutions have
been providing hospitals and clinicians, employers and health plans, state and federal government agencies, life sciences companies, and policymakers the facts they
need to make confident decisions that directly affect the health and well-being of people and organizations in the U.S. and around the world.
Truven Health Analytics owns some of the most trusted brands in healthcare, such as MarketScan,® 100 Top Hospitals,® Advantage Suite,® Micromedex,® Simpler,®
ActionOI,® and JWA. Truven Health has its principal offices in Ann Arbor, Mich.; Chicago, Ill.; and Denver, Colo. For more information, please visit truvenhealth.com.
truvenhealth.com
©2016 Truven Health Analytics, an IBM Company. All rights reserved. All other product names used herein are trademarks of their respective owners.
INTL 16670 0616